inflammatory bowel diseases
Conditions
Interventions
patients who take Moviprep
patients who take Niflec
Sponsors
Saitama Medical Center, Saitama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: IBD patients who undergo colonoscopy or transanal balloon enteroscopy IBD patients who can take laxative IBD patients who has wtitten informed consent form IBD patinets whose age are over 17 years old
Exclusion criteria
Exclusion criteria: Patients who has obstruction and/or suspicious obstruction of gastorointestinal tract Patients who has perforation and/or suspicious perforation ofgastorointestinal tract Patients who has delayed exhaust in stomach Patients with toxic megacolon Patients who has allergy of laxatives Patinets who are determiend not to be appropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clensing effects of laxatives | — |
Secondary
| Measure | Time frame |
|---|---|
| Persentage of patients who underwent colonoscopy Dose and time of laxatives for the preparation of colonoscopy Changes of body weight Blood chemistry and urine examination Clinical activity after colonoscopy Capability of using laxatives Adverse enents | — |
Countries
Japan
Contacts
Public ContactShingo Kato
Saitama Medical Center, Saitama Medical University Department of gastroenterology and hepatology
Outcome results
None listed